Arcus Biosciences initiated as Buy by TD Cowen
Benzinga reports TD Cowen initiated coverage on Arcus Biosciences with a Buy rating.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.